Amanda H. Anderson

Genome-Wide Association of CKD Progression: The Chronic Renal Insufficiency Cohort Study.

Janina M. Jeff, C. Fox, C. Winkler, 2017, Journal of the American Society of Nephrology : JASN.

Cardiac Biomarkers and Risk of Atherosclerotic Cardiovascular Disease in Patients with CKD

A. Go, E. Soliman, N. Bansal, 2022, Kidney360.

Proteomics of CKD progression in the chronic renal insufficiency cohort

R. Vasan, A. Parsa, J. Lash, 2023, Nature communications.

Novel Risk Factors for Progression of Diabetic and Nondiabetic CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.

Mahboob Rahman, M. Wolf, L. Appel, 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.

Mark E. Williams, P. Kimmel, A. Hung, 2019, Kidney international.

Analytic Considerations for Repeated Measures of eGFR in Cohort Studies of CKD.

J. Roy, C. Jepson, H. Feldman, 2017, Clinical journal of the American Society of Nephrology : CJASN.

Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study.

J. Charleston, V. Ford, Gail K. Makos, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Association of Blood Pressure Genetic Risk Score with Cardiovascular Disease and CKD Progression: Findings from the CRIC Study

T. Kelly, A. Parsa, S. Saraf, 2021, Kidney360.